Morpholine derivatives as norepinephrine reuptake inhibitors
申请人:Eli Lilly and Company
公开号:EP2223916A1
公开(公告)日:2010-09-01
Compounds of the general formula (I)
are inhibitors of the reuptake of norepinephrine. As such, they may be useful for the treatment of disorders of the central and/or peripheral nervous system.